Endios Bio
PrivateLast Round
Accelerator
May 15, 2025
Total Funding Raised
$50,000
Company Overview
Endios Bio operates in Healthcare & Life Sciences and is based in Baton Rouge, Louisiana. Its latest recorded funding round was an Accelerator round in May 2025.
Endios Bio is a biotechnology company developing breakthrough therapeutics for rare neurodegenerative diseases by targeting the PEG10 gene.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endios Bio Comparables
Compare Endios Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trace Neuroscience | 79% | |
| QurAlis | 74% | |
| Vico Therapeutics | 72% |
For institutional investors. Book with your work email.
Endios Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 15, 2025 | ||||
| Accelerator | Mar 19, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Endios Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Embark Deep Tech Startup Creator | Accelerator |
| NSF I-Corps Program | Accelerator |
| Innosphere Ventures | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2025
Innosphere Ventures participated in the Accelerator round.
- Mar 19, 2025
$50K raised from Embark Deep Tech and NSF I-Corps.
For institutional investors. Book with your work email.
Endios Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Endios Bio's valuation, stock price, and market status.
Is Endios Bio a public or private company?
Endios Bio is a private company.
What is the current stock price of Endios Bio?
Endios Bio is a private company, so its shares have no public market price. Caplight tracks Endios Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Endios Bio worth (valuation)?
Valuation information for Endios Bio is not publicly available.
Can I buy Endios Bio stock?
Endios Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Endios Bio's last funding round?
Endios Bio's most recent funding round was Accelerator on May 15, 2025.
Who are the main investors in Endios Bio?
Key investors in Endios Bio include Embark Deep Tech Startup Creator, NSF I-Corps Program, Innosphere Ventures.
Will Endios Bio IPO soon?
No public IPO plans have been announced for Endios Bio.
How can I track Endios Bio secondary market activity?
Caplight tracks bids, offers, and trades in Endios Bio's shares on secondary markets.